JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
CALL
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $2.37M | ﹤0.01% |
40,000
-50,000
| -56% | -$2.58M |
|
|
3127
PUT
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $2.37M | ﹤0.01% |
40,000
-50,000
| -56% | -$2.58M |
|
3128
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
| $2.37M | ﹤0.01% |
16,498
+9,918
| +151% | +$1.45M |
|
3129
M/I Homes
MHO
$3.9B
| $2.36M | ﹤0.01% |
60,024
-6,343
| -10% | -$265K |
|
3130
Hecla Mining
HL
$11.9B
| $2.35M | ﹤0.01% |
693,300
+367,706
| +113% | +$902K |
|
|
AKRO
3131
DELISTED
Akero Therapeutics
AKRO
| $2.35M | ﹤0.01% |
105,730
+21,763
| +26% | +$450K |
|
|
ZGNX
3132
PUT
DELISTED
Zogenix, Inc.
ZGNX
| $2.35M | ﹤0.01% |
45,000
-55,000
| -55% | -$2.52M |
|
|
ACBI
3133
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $2.35M | ﹤0.01% |
127,781
+4,744
| +4% | +$87.1K |
|
3134
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $2.34M | ﹤0.01% |
419,916
+298,141
| +245% | +$1.59M |
|
3135
Viper Energy
VNOM
$14.8B
| $2.34M | ﹤0.01% |
94,778
+65,803
| +227% | +$1.65M |
|
3136
Veracyte
VCYT
$3.42B
| $2.33M | ﹤0.01% |
83,584
+2,725
| +3% | +$70.5K |
|
3137
FS Bancorp
FSBW
$326M
| $2.33M | ﹤0.01% |
73,122
+3,060
| +4% | +$88.7K |
|
3138
Universal Corp
UVV
$1.12B
| $2.33M | ﹤0.01% |
40,848
-30,564
| -43% | -$1.65M |
|
3139
Commercial Vehicle Group
CVGI
$130M
| $2.33M | ﹤0.01% |
366,510
+81,452
| +29% | +$578K |
|
3140
PUT
Weibo
WB
$1.88B
| $2.32M | ﹤0.01% |
50,000
-30,000
| -38% | -$1.4M |
|
|
EFC
3141
Ellington Financial
EFC
$1.76B
| $2.32M | ﹤0.01% |
126,407
+81,097
| +179% | +$1.48M |
|
|
NGD
3142
DELISTED
New Gold Inc
NGD
| $2.31M | ﹤0.01% |
2,625,478
+617,381
| +31% | +$559K |
|
|
CHCT
3143
Community Healthcare Trust
CHCT
$433M
| $2.31M | ﹤0.01% |
53,839
+6,652
| +14% | +$303K |
|
3144
iShares US Utilities ETF
IDU
$1.38B
| $2.3M | ﹤0.01% |
28,338
+3,448
| +14% | +$275K |
|
|
LOMA
3145
Loma Negra
LOMA
$1.11B
| $2.3M | ﹤0.01% |
293,593
-168,011
| -36% | -$1.06M |
|
|
MODV
3146
DELISTED
ModivCare
MODV
| $2.29M | ﹤0.01% |
38,760
-8,846
| -19% | -$540K |
|
|
YARW
3147
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
| $2.29M | ﹤0.01% |
137
-11
| -7% | -$183K |
|
3148
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.39B
| $2.29M | ﹤0.01% |
33,365
-10,180
| -23% | -$670K |
|
3149
CALL
BioMarin Pharmaceuticals
BMRN
$13.3B
| $2.28M | ﹤0.01% |
+27,000
| New | +$2.04M |
|
|
3150
PUT
BioMarin Pharmaceuticals
BMRN
$13.3B
| $2.28M | ﹤0.01% |
27,000
+12,000
| +80% | +$906K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.